OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin

HTML

Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.13764
Authors: Juan P. Frias, Alan G. Wynne, Beata Matyjaszek‐Matuszek, Dagmar Bartaskova, David A. Cox, Brad Woodward, Ying G. Li, Lai S. Tham, Zvonko Milicevic
Institutions: National Research Institute, Medical University of Lublin, Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dulaglutide, type 2 diabetes, GLP-1 receptor agonists, dose escalation, metformin, HbA1c, glycemic control, weight loss, fasting serum glucose, drug safety, adverse events, hypoglycemia, nausea, dizziness, sleepiness
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2943546226
FWCI: 2.098
Cites: 22
Cited by: 50
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security